Agha W. Haider, MD, PhD; Martin G. Larson, ScD; Stanley S. Franklin, MD; Daniel Levy, MD
Grant Support: By contract N01-HC-38038 from the National Heart, Lung, and Blood Institute, National Institutes of Health. Dr. Haider's fellowship was supported in part by a grant from AstraZeneca Pharmaceuticals, Wayne, Pennsylvania.
Requests for Single Reprints: Daniel Levy, MD, Framingham Heart Study, 73 Mount Wayte Avenue, Suite 2, Framingham, MA 01702-5827.
Current Author Addresses: Dr. Haider: Cardiology Department, Drexel University College of Medicine, 3300 Henry Avenue, Philadelphia, PA 19129.
Dr. Franklin: University of California, Irvine, CA 92697.
Drs. Larson and Levy: Framingham Heart Study, 73 Mount Wayte Avenue, Suite 2, Framingham, MA 01702-5827.
Author Contributions: Conception and design: A.W. Haider, M.G. Larson, S.S. Franklin, D. Levy.
Analysis and interpretation of the data: A.W. Haider, M.G. Larson, D. Levy.
Drafting of the article: A.W. Haider, D. Levy.
Critical revision of the article for important intellectual content: A.W. Haider, M.G. Larson, D. Levy.
Final approval of the article: A.W. Haider, M.G. Larson, S.S. Franklin, D. Levy.
Obtaining of funding: A.W. Haider.
Statistical expertise: M.G. Larson.
Collection and assembly of data: M.G. Larson.
Haider A., Larson M., Franklin S., Levy D.; Systolic Blood Pressure, Diastolic Blood Pressure, and Pulse Pressure as Predictors of Risk for Congestive Heart Failure in the Framingham Heart Study. Ann Intern Med. 2003;138:10-16. doi: 10.7326/0003-4819-138-1-200301070-00006
Download citation file:
Published: Ann Intern Med. 2003;138(1):10-16.
Hypertension is the most common risk factor for congestive heart failure (CHF). It confers a twofold risk for the occurrence of CHF and also carries the highest population attributable risk among all risk factors for CHF (1, 2). Placebo-controlled clinical trials in patients with hypertension have demonstrated a consistent reduction in risk for CHF attributable to the lowering of elevated blood pressure (3-6). The causal role of hypertension in the pathogenesis of CHF underscores the need to identify high-risk patients because early treatment may prevent or delay the occurrence of CHF (2, 7).
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Cardiology, Heart Failure.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only